Department of Anaesthesiology, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal.
Department of Otolaryngology-Head and Neck Surgery, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal.
JNMA J Nepal Med Assoc. 2021 Sep 11;59(241):965-967. doi: 10.31729/jnma.6686.
The rapid surge of COVID-19 cases in the second wave of the pandemic has crippled the healthcare delivery system in Nepal and neighboring countries. Unlike in the first wave of the pandemic, several cases of mucormycosis have been reported in patients with COVID-19 from Nepal and India. In this report, we briefly describe the clinical presentation, diagnosis, and risk factors for mucormycosis and explore why patients with COVID-19 are at an increased risk for developing the infection. As treatment of mucormycosis is challenging and consumes a lot of resources, prevention of mucormycosis is pivotal in low-income countries like Nepal. We also highlight some basic steps that are easy to perform and important to reduce the risk of infection.
第二波大流行期间 COVID-19 病例的迅速激增，使尼泊尔和邻国的医疗保健系统陷入瘫痪。与大流行的第一波不同，尼泊尔和印度的 COVID-19 患者中报告了几例毛霉菌病病例。在本报告中，我们简要描述了毛霉菌病的临床表现、诊断和危险因素，并探讨了为什么 COVID-19 患者感染的风险增加。由于毛霉菌病的治疗具有挑战性且消耗大量资源，因此像尼泊尔这样的低收入国家预防毛霉菌病至关重要。我们还强调了一些易于实施且对降低感染风险很重要的基本步骤。
